Iroquois Capital Management, LLC 13D and 13G filings for Artelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-23 4:36 pm Sale |
2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Iroquois Capital Management, LLC | 6,667 0.240% |
-54,667 (-89.13%) |
Filing |
| 2020-10-19 3:25 pm Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
Iroquois Capital Management, LLC | 61,333 6.670% |
61,333 (New Position) |
Filing |